Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SLAMF7 anticorps (AA 249-335)

SLAMF7 Reactivité: Humain IHC (f) Hôte: Souris Monoclonal unconjugated
N° du produit ABIN7126855
  • Antigène Voir toutes SLAMF7 Anticorps
    SLAMF7 (SLAM Family Member 7 (SLAMF7))
    Épitope
    • 16
    • 7
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    AA 249-335
    Reactivité
    • 44
    • 23
    • 3
    Humain
    Hôte
    • 31
    • 14
    • 3
    Souris
    Clonalité
    • 34
    • 14
    Monoclonal
    Conjugué
    • 23
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SLAMF7 est non-conjugé
    Application
    • 37
    • 22
    • 18
    • 9
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Specificité
    CS1, also known as novel Ly9, SLAMF7, 19A24 or CRACC, is a homophilic cell surface receptor. It is a member of the SLAM (signaling lymphocytic activation molecule) family of receptors expressed on natural killer (NK) cells, T cells and stimulated B cells. CS1 contains immunoreceptor tyrosine-based switch motifs in its cytoplasmic domain but, unlike other SLAM receptors, it does not recruit SAP (SLAM-associated protein). In humans, CS1 activates NK cells through an EAT-2-mediated pathway that is SAP-independent. CS1 recruits and associates with EAT-2, a protein closely related to SAP. EAT-2 induces phosphorylation of CS1 which then, upon ligand binding, activates downstream cytotoxicity effectors PLC and PI 3K. In mice, the EAT-2 association with CS1 has an inhibitory effect on the activation of NK cells.
    Réactivité croisée (Details)
    Human.
    Purification
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogène
    Recombinant fragment of human SLAMF7 protein (around aa 249-335) (exact sequence is proprietary)
    Isotype
    IgG1
    Top Product
    Discover our top product SLAMF7 Anticorps primaire
  • Indications d'application

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil tissue.

    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Agent conservateur
    Azide free
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Date de péremption
    24 months
  • Antigène
    SLAMF7 (SLAM Family Member 7 (SLAMF7))
    Autre désignation
    SLAMF7 (SLAMF7 Produits)
    Synonymes
    anticorps RGD1560190, anticorps SLAMF7, anticorps slaf7, anticorps 19A, anticorps CD319, anticorps CRACC, anticorps CS1, anticorps 19A24, anticorps 4930560D03Rik, anticorps SLAM family member 7, anticorps Slamf7, anticorps SLAMF7, anticorps slaf7
    Sujet
    19A, 19A24 protein, CD2 like receptor activating cytotoxic cells, CD2 subset 1, CRACC, CS1, Membrane protein FOAP 12, Novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7,SLAMF7 / CS1 / CD319
    Cellular localisation: Cell surface
    Poids moléculaire
    37kDa
    ID gène
    57823, 517265
    UniProt
    Q9NQ25
Vous êtes ici: